Pharma & Healthcare
Global Human Coagulation Factor VII Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 301325
- Pages: 106
- Figures: 105
- Views: 1
In 2024, the global market size of Human Coagulation Factor VII was estimated to be worth US$ 1251 million and is forecast to reach approximately US$ 1608 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
In its recombinant form, Recombinant Human Coagulation Factor VIIa (rFVIIa) is used as a medication to help control bleeding, particularly in patients with hemophilia or other bleeding disorders who have developed inhibitors to conventional therapies.
Drivers of the Recombinant Human Coagulation Factor VII Market:
Rising Prevalence of Hemophilia and Bleeding Disorders: Recombinant Factor VIIa is primarily used in treating hemophilia, especially in patients with inhibitors to Factor VIII or IX. The growing global incidence of hemophilia and other bleeding disorders is a major driver of market demand.
Advancements in Recombinant Technology: Ongoing improvements in biotechnology have led to the development of safer and more effective recombinant coagulation products. These advancements reduce the risk of bloodborne pathogen transmission, increasing their adoption over plasma-derived alternatives.
Increased Use in Trauma and Surgery: Recombinant Factor VIIa is also used in managing severe bleeding during trauma and surgical procedures, further expanding its clinical applications and boosting demand, particularly in emergency care settings.
Rising Adoption in Off-Label Uses: While its primary indication is for hemophilia, rFVIIa is increasingly being used off-label to manage uncontrolled bleeding in non-hemophiliac patients, particularly in critical care and trauma settings. This broadens its potential market.
Favorable Reimbursement Policies in Developed Regions: In regions like North America and Europe, the availability of comprehensive insurance and reimbursement for advanced therapies like rFVIIa makes these treatments more accessible to patients, supporting market growth.
Challenges of the Recombinant Human Coagulation Factor VII Market:
High Cost of Treatment: Recombinant Factor VIIa therapy is expensive, which can limit access, especially in low-income countries and regions without robust healthcare funding or insurance coverage.
Potential for Off-Label Use Concerns: Despite its increasing use in off-label applications, concerns about the safety and efficacy of rFVIIa in non-hemophilia patients have led to caution in its broader application. Regulatory scrutiny on off-label use may impact market expansion.
Limited Awareness and Access in Developing Regions: In many developing countries, awareness of recombinant therapies for hemophilia is limited, and access to advanced treatments is constrained by inadequate healthcare infrastructure and funding.
Competition from Alternative Therapies: Emerging gene therapies, extended half-life clotting factors, and other innovative treatments for hemophilia may compete with or reduce the demand for rFVIIa in the future. These newer therapies promise more long-term efficacy or convenience.
Regulatory Challenges: The stringent regulatory approval process for biologics, along with the ongoing need for post-market surveillance, can slow down the introduction of new products or indications, impacting the pace of market growth.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VII.
The Human Coagulation Factor VII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor VII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
NovoNordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Segment by Type
Prefilled Syringe
Vial
Segment by Application
Congenital Hemophilia
Acquired Hemophilia
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Coagulation Factor VII in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VII sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Human Coagulation Factor VII is a protein that plays a crucial role in the blood clotting process (hemostasis). It is one of the key components of the extrinsic pathway of the coagulation cascade, which is activated when tissue damage occurs. Factor VII works by binding to tissue factor (TF) exposed at the site of injury, forming a complex that activates other clotting factors (such as Factor X and Factor IX), ultimately leading to the formation of a blood clot.
In its recombinant form, Recombinant Human Coagulation Factor VIIa (rFVIIa) is used as a medication to help control bleeding, particularly in patients with hemophilia or other bleeding disorders who have developed inhibitors to conventional therapies.
Drivers of the Recombinant Human Coagulation Factor VII Market:
Rising Prevalence of Hemophilia and Bleeding Disorders: Recombinant Factor VIIa is primarily used in treating hemophilia, especially in patients with inhibitors to Factor VIII or IX. The growing global incidence of hemophilia and other bleeding disorders is a major driver of market demand.
Advancements in Recombinant Technology: Ongoing improvements in biotechnology have led to the development of safer and more effective recombinant coagulation products. These advancements reduce the risk of bloodborne pathogen transmission, increasing their adoption over plasma-derived alternatives.
Increased Use in Trauma and Surgery: Recombinant Factor VIIa is also used in managing severe bleeding during trauma and surgical procedures, further expanding its clinical applications and boosting demand, particularly in emergency care settings.
Rising Adoption in Off-Label Uses: While its primary indication is for hemophilia, rFVIIa is increasingly being used off-label to manage uncontrolled bleeding in non-hemophiliac patients, particularly in critical care and trauma settings. This broadens its potential market.
Favorable Reimbursement Policies in Developed Regions: In regions like North America and Europe, the availability of comprehensive insurance and reimbursement for advanced therapies like rFVIIa makes these treatments more accessible to patients, supporting market growth.
Challenges of the Recombinant Human Coagulation Factor VII Market:
High Cost of Treatment: Recombinant Factor VIIa therapy is expensive, which can limit access, especially in low-income countries and regions without robust healthcare funding or insurance coverage.
Potential for Off-Label Use Concerns: Despite its increasing use in off-label applications, concerns about the safety and efficacy of rFVIIa in non-hemophilia patients have led to caution in its broader application. Regulatory scrutiny on off-label use may impact market expansion.
Limited Awareness and Access in Developing Regions: In many developing countries, awareness of recombinant therapies for hemophilia is limited, and access to advanced treatments is constrained by inadequate healthcare infrastructure and funding.
Competition from Alternative Therapies: Emerging gene therapies, extended half-life clotting factors, and other innovative treatments for hemophilia may compete with or reduce the demand for rFVIIa in the future. These newer therapies promise more long-term efficacy or convenience.
Regulatory Challenges: The stringent regulatory approval process for biologics, along with the ongoing need for post-market surveillance, can slow down the introduction of new products or indications, impacting the pace of market growth.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VII.
The Human Coagulation Factor VII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Coagulation Factor VII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor VII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
NovoNordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Segment by Type
Prefilled Syringe
Vial
Segment by Application
Congenital Hemophilia
Acquired Hemophilia
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Coagulation Factor VII in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Human Coagulation Factor VII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VII sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Human Coagulation Factor VII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VII Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prefilled Syringe
1.2.3 Vial
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VII Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Congenital Hemophilia
1.3.3 Acquired Hemophilia
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor VII Market Size Estimates and Forecasts
2.1.1 Global Human Coagulation Factor VII Revenue 2020-2031
2.1.2 Global Human Coagulation Factor VII Sales 2020-2031
2.2 Human Coagulation Factor VII Market Size by Region: 2024 Versus 2031
2.3 Human Coagulation Factor VII Sales by Region (2020-2031)
2.3.1 Global Human Coagulation Factor VII Sales by Region: 2020-2025
2.3.2 Global Human Coagulation Factor VII Sales Forecast by Region (2026-2031)
2.3.3 Global Human Coagulation Factor VII Sales Market Share by Region (2020-2031)
2.4 Human Coagulation Factor VII Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Coagulation Factor VII Revenue by Region: 2020-2025
2.4.2 Global Human Coagulation Factor VII Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Coagulation Factor VII Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Coagulation Factor VII Sales by Type (2020-2031)
3.1.1.1 Global Human Coagulation Factor VII Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Coagulation Factor VII Sales Market Share by Type (2020-2031)
3.1.2 Global Human Coagulation Factor VII Revenue by Type (2020-2031)
3.1.2.1 Global Human Coagulation Factor VII Revenue by Type (2020-2031)
3.1.2.2 Global Human Coagulation Factor VII Revenue Market Share by Type (2020-2031)
3.1.3 Human Coagulation Factor VII Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Coagulation Factor VII Sales by Application (2020-2031)
3.2.1.1 Global Human Coagulation Factor VII Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Coagulation Factor VII Sales Market Share by Application (2020-2031)
3.2.2 Global Human Coagulation Factor VII Revenue by Application (2020-2031)
3.2.2.1 Global Human Coagulation Factor VII Revenue by Application (2020-2031)
3.2.2.2 Global Human Coagulation Factor VII Revenue Market Share by Application (2020-2031)
3.2.3 Human Coagulation Factor VII Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prefilled Syringe of Human Coagulation Factor VII Revenue Market Share by Application
3.3.2 Vial of Human Coagulation Factor VII Revenue Market Share by Application
4 Global Human Coagulation Factor VII by Manufacturers
4.1 Global Top Human Coagulation Factor VII Manufacturers by Sales (2020-2025)
4.1.1 Global Human Coagulation Factor VII Sales by Manufacturer (2020-2025)
4.1.2 Global Human Coagulation Factor VII Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Coagulation Factor VII Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Coagulation Factor VII Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Coagulation Factor VII Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Coagulation Factor VII Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Coagulation Factor VII Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Coagulation Factor VII Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Coagulation Factor VII Manufacturing Base Distribution, Product Type
4.5.1 Human Coagulation Factor VII Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Coagulation Factor VII Market
4.5.3 Manufacturers Human Coagulation Factor VII Product Type and Application
4.5.4 Prefilled Syringe Market Sales of Human Coagulation Factor VII by Manufacturer
4.5.5 Vial Market Sales of Human Coagulation Factor VII by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 NovoNordisk
5.1.1 NovoNordisk Company Information
5.1.2 NovoNordisk Description, Business Overview
5.1.3 NovoNordisk Human Coagulation Factor VII Products Offered
5.1.4 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.1.5 NovoNordisk Human Coagulation Factor VII Sales by Product in 2024
5.1.6 NovoNordisk Human Coagulation Factor VII Sales by Application in 2024
5.1.7 NovoNordisk Human Coagulation Factor VII Sales by Geographic Area in 2024
5.1.8 NovoNordisk Recent Developments
5.2 LFB SA HEMA Biologics
5.2.1 LFB SA HEMA Biologics Company Information
5.2.2 LFB SA HEMA Biologics Description, Business Overview
5.2.3 LFB SA HEMA Biologics Human Coagulation Factor VII Products Offered
5.2.4 LFB SA HEMA Biologics Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.2.5 LFB SA HEMA Biologics Human Coagulation Factor VII Sales by Product in 2024
5.2.6 LFB SA HEMA Biologics Human Coagulation Factor VII Sales by Application in 2024
5.2.7 LFB SA HEMA Biologics Human Coagulation Factor VII Sales by Geographic Area in 2024
5.2.8 LFB SA HEMA Biologics Recent Developments
5.3 AryoGen Pharmed
5.3.1 AryoGen Pharmed Company Information
5.3.2 AryoGen Pharmed Description, Business Overview
5.3.3 AryoGen Pharmed Human Coagulation Factor VII Products Offered
5.3.4 AryoGen Pharmed Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.3.5 AryoGen Pharmed Human Coagulation Factor VII Sales by Product in 2024
5.3.6 AryoGen Pharmed Human Coagulation Factor VII Sales by Application in 2024
5.3.7 AryoGen Pharmed Human Coagulation Factor VII Sales by Geographic Area in 2024
5.3.8 AryoGen Pharmed Recent Developments
5.4 GENERIUM
5.4.1 GENERIUM Company Information
5.4.2 GENERIUM Description, Business Overview
5.4.3 GENERIUM Human Coagulation Factor VII Products Offered
5.4.4 GENERIUM Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.4.5 GENERIUM Human Coagulation Factor VII Sales by Product in 2024
5.4.6 GENERIUM Human Coagulation Factor VII Sales by Application in 2024
5.4.7 GENERIUM Human Coagulation Factor VII Sales by Geographic Area in 2024
5.4.8 GENERIUM Recent Developments
6 North America
6.1 North America Human Coagulation Factor VII Market Size YoY Growth 2020-2031
6.2 North America Human Coagulation Factor VII Market Facts & Figures by Country
6.2.1 North America Human Coagulation Factor VII Sales by Country (2020-2031)
6.2.2 North America Human Coagulation Factor VII Revenue by Country (2020-2031)
6.3 North America Human Coagulation Factor VII Sales by Type (2020-2025)
6.4 North America Human Coagulation Factor VII Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Coagulation Factor VII Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Coagulation Factor VII Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Coagulation Factor VII Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Coagulation Factor VII Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Coagulation Factor VII Sales by Type (2020-2025)
7.4 Asia-Pacific Human Coagulation Factor VII Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Coagulation Factor VII Market Size YoY Growth 2020-2031
8.2 Europe Human Coagulation Factor VII Market Facts & Figures by Country
8.2.1 Europe Human Coagulation Factor VII Sales by Country (2020-2031)
8.2.2 Europe Human Coagulation Factor VII Revenue by Country (2020-2031)
8.3 Europe Human Coagulation Factor VII Sales by Type (2020-2025)
8.4 Europe Human Coagulation Factor VII Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Coagulation Factor VII Market Size YoY Growth 2020-2031
9.2 Latin America Human Coagulation Factor VII Market Facts & Figures by Country
9.2.1 Latin America Human Coagulation Factor VII Sales by Country (2020-2031)
9.2.2 Latin America Human Coagulation Factor VII Revenue by Country (2020-2031)
9.3 Latin America Human Coagulation Factor VII Sales by Type (2020-2025)
9.4 Latin America Human Coagulation Factor VII Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Coagulation Factor VII Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Coagulation Factor VII Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Coagulation Factor VII Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Coagulation Factor VII Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Coagulation Factor VII Sales by Type (2020-2025)
10.4 Middle East and Africa Human Coagulation Factor VII Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Coagulation Factor VII Supply Chain Analysis
11.2 Human Coagulation Factor VII Key Raw Materials and Upstream Suppliers
11.3 Human Coagulation Factor VII Clients Analysis
11.4 Human Coagulation Factor VII Sales Channel and Sales Model Analysis
11.4.1 Human Coagulation Factor VII Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Coagulation Factor VII Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Coagulation Factor VII Distributors
12 Human Coagulation Factor VII Market Dynamics
12.1 Human Coagulation Factor VII Industry Trends
12.2 Human Coagulation Factor VII Market Drivers
12.3 Human Coagulation Factor VII Market Challenges
12.4 Human Coagulation Factor VII Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Human Coagulation Factor VII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VII Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Prefilled Syringe
1.2.3 Vial
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VII Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Congenital Hemophilia
1.3.3 Acquired Hemophilia
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor VII Market Size Estimates and Forecasts
2.1.1 Global Human Coagulation Factor VII Revenue 2020-2031
2.1.2 Global Human Coagulation Factor VII Sales 2020-2031
2.2 Human Coagulation Factor VII Market Size by Region: 2024 Versus 2031
2.3 Human Coagulation Factor VII Sales by Region (2020-2031)
2.3.1 Global Human Coagulation Factor VII Sales by Region: 2020-2025
2.3.2 Global Human Coagulation Factor VII Sales Forecast by Region (2026-2031)
2.3.3 Global Human Coagulation Factor VII Sales Market Share by Region (2020-2031)
2.4 Human Coagulation Factor VII Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Coagulation Factor VII Revenue by Region: 2020-2025
2.4.2 Global Human Coagulation Factor VII Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Coagulation Factor VII Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Coagulation Factor VII Sales by Type (2020-2031)
3.1.1.1 Global Human Coagulation Factor VII Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Coagulation Factor VII Sales Market Share by Type (2020-2031)
3.1.2 Global Human Coagulation Factor VII Revenue by Type (2020-2031)
3.1.2.1 Global Human Coagulation Factor VII Revenue by Type (2020-2031)
3.1.2.2 Global Human Coagulation Factor VII Revenue Market Share by Type (2020-2031)
3.1.3 Human Coagulation Factor VII Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Coagulation Factor VII Sales by Application (2020-2031)
3.2.1.1 Global Human Coagulation Factor VII Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Coagulation Factor VII Sales Market Share by Application (2020-2031)
3.2.2 Global Human Coagulation Factor VII Revenue by Application (2020-2031)
3.2.2.1 Global Human Coagulation Factor VII Revenue by Application (2020-2031)
3.2.2.2 Global Human Coagulation Factor VII Revenue Market Share by Application (2020-2031)
3.2.3 Human Coagulation Factor VII Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Prefilled Syringe of Human Coagulation Factor VII Revenue Market Share by Application
3.3.2 Vial of Human Coagulation Factor VII Revenue Market Share by Application
4 Global Human Coagulation Factor VII by Manufacturers
4.1 Global Top Human Coagulation Factor VII Manufacturers by Sales (2020-2025)
4.1.1 Global Human Coagulation Factor VII Sales by Manufacturer (2020-2025)
4.1.2 Global Human Coagulation Factor VII Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Coagulation Factor VII Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Coagulation Factor VII Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Coagulation Factor VII Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Coagulation Factor VII Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Coagulation Factor VII Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Coagulation Factor VII Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Coagulation Factor VII Manufacturing Base Distribution, Product Type
4.5.1 Human Coagulation Factor VII Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Coagulation Factor VII Market
4.5.3 Manufacturers Human Coagulation Factor VII Product Type and Application
4.5.4 Prefilled Syringe Market Sales of Human Coagulation Factor VII by Manufacturer
4.5.5 Vial Market Sales of Human Coagulation Factor VII by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 NovoNordisk
5.1.1 NovoNordisk Company Information
5.1.2 NovoNordisk Description, Business Overview
5.1.3 NovoNordisk Human Coagulation Factor VII Products Offered
5.1.4 NovoNordisk Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.1.5 NovoNordisk Human Coagulation Factor VII Sales by Product in 2024
5.1.6 NovoNordisk Human Coagulation Factor VII Sales by Application in 2024
5.1.7 NovoNordisk Human Coagulation Factor VII Sales by Geographic Area in 2024
5.1.8 NovoNordisk Recent Developments
5.2 LFB SA HEMA Biologics
5.2.1 LFB SA HEMA Biologics Company Information
5.2.2 LFB SA HEMA Biologics Description, Business Overview
5.2.3 LFB SA HEMA Biologics Human Coagulation Factor VII Products Offered
5.2.4 LFB SA HEMA Biologics Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.2.5 LFB SA HEMA Biologics Human Coagulation Factor VII Sales by Product in 2024
5.2.6 LFB SA HEMA Biologics Human Coagulation Factor VII Sales by Application in 2024
5.2.7 LFB SA HEMA Biologics Human Coagulation Factor VII Sales by Geographic Area in 2024
5.2.8 LFB SA HEMA Biologics Recent Developments
5.3 AryoGen Pharmed
5.3.1 AryoGen Pharmed Company Information
5.3.2 AryoGen Pharmed Description, Business Overview
5.3.3 AryoGen Pharmed Human Coagulation Factor VII Products Offered
5.3.4 AryoGen Pharmed Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.3.5 AryoGen Pharmed Human Coagulation Factor VII Sales by Product in 2024
5.3.6 AryoGen Pharmed Human Coagulation Factor VII Sales by Application in 2024
5.3.7 AryoGen Pharmed Human Coagulation Factor VII Sales by Geographic Area in 2024
5.3.8 AryoGen Pharmed Recent Developments
5.4 GENERIUM
5.4.1 GENERIUM Company Information
5.4.2 GENERIUM Description, Business Overview
5.4.3 GENERIUM Human Coagulation Factor VII Products Offered
5.4.4 GENERIUM Human Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
5.4.5 GENERIUM Human Coagulation Factor VII Sales by Product in 2024
5.4.6 GENERIUM Human Coagulation Factor VII Sales by Application in 2024
5.4.7 GENERIUM Human Coagulation Factor VII Sales by Geographic Area in 2024
5.4.8 GENERIUM Recent Developments
6 North America
6.1 North America Human Coagulation Factor VII Market Size YoY Growth 2020-2031
6.2 North America Human Coagulation Factor VII Market Facts & Figures by Country
6.2.1 North America Human Coagulation Factor VII Sales by Country (2020-2031)
6.2.2 North America Human Coagulation Factor VII Revenue by Country (2020-2031)
6.3 North America Human Coagulation Factor VII Sales by Type (2020-2025)
6.4 North America Human Coagulation Factor VII Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Coagulation Factor VII Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Coagulation Factor VII Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Coagulation Factor VII Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Coagulation Factor VII Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Coagulation Factor VII Sales by Type (2020-2025)
7.4 Asia-Pacific Human Coagulation Factor VII Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Coagulation Factor VII Market Size YoY Growth 2020-2031
8.2 Europe Human Coagulation Factor VII Market Facts & Figures by Country
8.2.1 Europe Human Coagulation Factor VII Sales by Country (2020-2031)
8.2.2 Europe Human Coagulation Factor VII Revenue by Country (2020-2031)
8.3 Europe Human Coagulation Factor VII Sales by Type (2020-2025)
8.4 Europe Human Coagulation Factor VII Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Coagulation Factor VII Market Size YoY Growth 2020-2031
9.2 Latin America Human Coagulation Factor VII Market Facts & Figures by Country
9.2.1 Latin America Human Coagulation Factor VII Sales by Country (2020-2031)
9.2.2 Latin America Human Coagulation Factor VII Revenue by Country (2020-2031)
9.3 Latin America Human Coagulation Factor VII Sales by Type (2020-2025)
9.4 Latin America Human Coagulation Factor VII Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Coagulation Factor VII Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Coagulation Factor VII Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Coagulation Factor VII Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Coagulation Factor VII Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Coagulation Factor VII Sales by Type (2020-2025)
10.4 Middle East and Africa Human Coagulation Factor VII Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Coagulation Factor VII Supply Chain Analysis
11.2 Human Coagulation Factor VII Key Raw Materials and Upstream Suppliers
11.3 Human Coagulation Factor VII Clients Analysis
11.4 Human Coagulation Factor VII Sales Channel and Sales Model Analysis
11.4.1 Human Coagulation Factor VII Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Coagulation Factor VII Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Coagulation Factor VII Distributors
12 Human Coagulation Factor VII Market Dynamics
12.1 Human Coagulation Factor VII Industry Trends
12.2 Human Coagulation Factor VII Market Drivers
12.3 Human Coagulation Factor VII Market Challenges
12.4 Human Coagulation Factor VII Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VII Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Coagulation Factor VII Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Coagulation Factor VII Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
Table 5. Global Human Coagulation Factor VII Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Human Coagulation Factor VII Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Human Coagulation Factor VII Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Human Coagulation Factor VII Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Human Coagulation Factor VII Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Human Coagulation Factor VII Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Human Coagulation Factor VII Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Human Coagulation Factor VII Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Human Coagulation Factor VII Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Human Coagulation Factor VII Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Human Coagulation Factor VII Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Human Coagulation Factor VII Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Human Coagulation Factor VII Sales Share by Manufacturer (2020-2025)
Table 18. Human Coagulation Factor VII Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Human Coagulation Factor VII Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Human Coagulation Factor VII Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Human Coagulation Factor VII Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Human Coagulation Factor VII Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Human Coagulation Factor VII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VII as of 2024)
Table 24. Human Coagulation Factor VII Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Human Coagulation Factor VII Market
Table 26. Manufacturers Human Coagulation Factor VII Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. NovoNordisk Company Information
Table 29. NovoNordisk Description and Business Overview
Table 30. NovoNordisk Human Coagulation Factor VII Product
Table 31. NovoNordisk Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. NovoNordisk Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 33. NovoNordisk Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 34. NovoNordisk Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 35. NovoNordisk Recent Developments
Table 36. LFB SA HEMA Biologics Company Information
Table 37. LFB SA HEMA Biologics Description and Business Overview
Table 38. LFB SA HEMA Biologics Human Coagulation Factor VII Product
Table 39. LFB SA HEMA Biologics Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. LFB SA HEMA Biologics Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 41. LFB SA HEMA Biologics Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 42. LFB SA HEMA Biologics Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 43. LFB SA HEMA Biologics Recent Developments
Table 44. AryoGen Pharmed Company Information
Table 45. AryoGen Pharmed Description and Business Overview
Table 46. AryoGen Pharmed Human Coagulation Factor VII Product
Table 47. AryoGen Pharmed Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. AryoGen Pharmed Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 49. AryoGen Pharmed Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 50. AryoGen Pharmed Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 51. AryoGen Pharmed Recent Developments
Table 52. GENERIUM Company Information
Table 53. GENERIUM Description and Business Overview
Table 54. GENERIUM Human Coagulation Factor VII Product
Table 55. GENERIUM Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. GENERIUM Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 57. GENERIUM Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 58. GENERIUM Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 59. GENERIUM Recent Developments
Table 60. North America Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 61. North America Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 62. North America Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 63. North America Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 64. North America Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 65. North America Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 66. Asia-Pacific Human Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
Table 67. Asia-Pacific Human Coagulation Factor VII Sales by Region (2026-2031) & (K Units)
Table 68. Asia-Pacific Human Coagulation Factor VII Revenue by Region (2020-2025) & (US$ Million)
Table 69. Asia-Pacific Human Coagulation Factor VII Revenue by Region (2026-2031) & (US$ Million)
Table 70. Asia-Pacific Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 71. Asia-Pacific Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 72. Europe Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 73. Europe Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 74. Europe Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 75. Europe Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 76. Europe Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 77. Europe Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 78. Latin America Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 79. Latin America Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 80. Latin America Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 81. Latin America Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 82. Latin America Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 83. Latin America Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 84. Middle East and Africa Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 85. Middle East and Africa Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 86. Middle East and Africa Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 87. Middle East and Africa Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 88. Middle East and Africa Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 89. Middle East and Africa Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 90. Human Coagulation Factor VII Key Raw Materials, Industry Status and Trend
Table 91. Human Coagulation Factor VII Key Raw Materials and Upstream Suppliers
Table 92. Human Coagulation Factor VII Clients Status and Trend
Table 93. Human Coagulation Factor VII Typical Clients
Table 94. Human Coagulation Factor VII Distributors
Table 95. Human Coagulation Factor VII Market Trends
Table 96. Human Coagulation Factor VII Market Drivers
Table 97. Human Coagulation Factor VII Market Challenges
Table 98. Human Coagulation Factor VII Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Coagulation Factor VII Product Picture
Figure 2. Global Human Coagulation Factor VII Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Coagulation Factor VII Sales Market Share by Type in 2024 & 2031
Figure 4. Prefilled Syringe Product Picture
Figure 5. Vial Product Picture
Figure 6. Global Human Coagulation Factor VII Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Human Coagulation Factor VII Sales Market Share by Application in 2024 & 2031
Figure 8. Congenital Hemophilia
Figure 9. Acquired Hemophilia
Figure 10. Other
Figure 11. Human Coagulation Factor VII Report Years Considered
Figure 12. Global Human Coagulation Factor VII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor VII Market Size 2020-2031 (US$ Million)
Figure 14. Global Human Coagulation Factor VII Sales 2020-2031 (K Units)
Figure 15. Global Human Coagulation Factor VII Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Human Coagulation Factor VII Revenue Market Share by Region (2020-2031)
Figure 17. Global Human Coagulation Factor VII Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Human Coagulation Factor VII Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Human Coagulation Factor VII Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Human Coagulation Factor VII Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Human Coagulation Factor VII Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Human Coagulation Factor VII Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Prefilled Syringe of Human Coagulation Factor VII Revenue Market Share by Application, 2024 VS 2031
Figure 24. Vial of Human Coagulation Factor VII Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Human Coagulation Factor VII Sales Share by Manufacturer in 2024
Figure 26. Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Prefilled Syringe Market Sales Proportion by Manufacturer in 2024
Figure 28. Vial Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Human Coagulation Factor VII Revenue 2020-2031 (US$ Million)
Figure 30. North America Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 31. North America Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Human Coagulation Factor VII Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Human Coagulation Factor VII Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 37. Europe Human Coagulation Factor VII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Human Coagulation Factor VII Sales Market Share by Country (2020-2031)
Figure 39. Europe Human Coagulation Factor VII Revenue Market Share by Country (2020-2031)
Figure 40. Europe Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 41. Europe Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 42. Latin America Human Coagulation Factor VII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Human Coagulation Factor VII Sales Market Share by Country (2020-2031)
Figure 44. Latin America Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 46. Latin America Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Human Coagulation Factor VII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Coagulation Factor VII Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 52. Human Coagulation Factor VII Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Human Coagulation Factor VII Raw Materials by Region in 2024
Figure 54. Human Coagulation Factor VII Distribution Channels
Figure 55. Global Human Coagulation Factor VII Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Human Coagulation Factor VII Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Human Coagulation Factor VII Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Coagulation Factor VII Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Human Coagulation Factor VII Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Human Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
Table 5. Global Human Coagulation Factor VII Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Human Coagulation Factor VII Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Human Coagulation Factor VII Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Human Coagulation Factor VII Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Human Coagulation Factor VII Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Human Coagulation Factor VII Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Human Coagulation Factor VII Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Human Coagulation Factor VII Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Human Coagulation Factor VII Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Human Coagulation Factor VII Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Human Coagulation Factor VII Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Human Coagulation Factor VII Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Human Coagulation Factor VII Sales Share by Manufacturer (2020-2025)
Table 18. Human Coagulation Factor VII Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Human Coagulation Factor VII Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Human Coagulation Factor VII Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Human Coagulation Factor VII Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Human Coagulation Factor VII Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Human Coagulation Factor VII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VII as of 2024)
Table 24. Human Coagulation Factor VII Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Human Coagulation Factor VII Market
Table 26. Manufacturers Human Coagulation Factor VII Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. NovoNordisk Company Information
Table 29. NovoNordisk Description and Business Overview
Table 30. NovoNordisk Human Coagulation Factor VII Product
Table 31. NovoNordisk Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. NovoNordisk Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 33. NovoNordisk Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 34. NovoNordisk Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 35. NovoNordisk Recent Developments
Table 36. LFB SA HEMA Biologics Company Information
Table 37. LFB SA HEMA Biologics Description and Business Overview
Table 38. LFB SA HEMA Biologics Human Coagulation Factor VII Product
Table 39. LFB SA HEMA Biologics Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. LFB SA HEMA Biologics Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 41. LFB SA HEMA Biologics Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 42. LFB SA HEMA Biologics Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 43. LFB SA HEMA Biologics Recent Developments
Table 44. AryoGen Pharmed Company Information
Table 45. AryoGen Pharmed Description and Business Overview
Table 46. AryoGen Pharmed Human Coagulation Factor VII Product
Table 47. AryoGen Pharmed Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. AryoGen Pharmed Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 49. AryoGen Pharmed Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 50. AryoGen Pharmed Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 51. AryoGen Pharmed Recent Developments
Table 52. GENERIUM Company Information
Table 53. GENERIUM Description and Business Overview
Table 54. GENERIUM Human Coagulation Factor VII Product
Table 55. GENERIUM Human Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. GENERIUM Sales Proportion of Human Coagulation Factor VII by Product in 2024
Table 57. GENERIUM Sales Proportion of Human Coagulation Factor VII by Application in 2024
Table 58. GENERIUM Sales Proportion of Human Coagulation Factor VII by Geographic Area in 2024
Table 59. GENERIUM Recent Developments
Table 60. North America Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 61. North America Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 62. North America Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 63. North America Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 64. North America Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 65. North America Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 66. Asia-Pacific Human Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
Table 67. Asia-Pacific Human Coagulation Factor VII Sales by Region (2026-2031) & (K Units)
Table 68. Asia-Pacific Human Coagulation Factor VII Revenue by Region (2020-2025) & (US$ Million)
Table 69. Asia-Pacific Human Coagulation Factor VII Revenue by Region (2026-2031) & (US$ Million)
Table 70. Asia-Pacific Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 71. Asia-Pacific Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 72. Europe Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 73. Europe Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 74. Europe Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 75. Europe Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 76. Europe Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 77. Europe Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 78. Latin America Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 79. Latin America Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 80. Latin America Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 81. Latin America Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 82. Latin America Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 83. Latin America Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 84. Middle East and Africa Human Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
Table 85. Middle East and Africa Human Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
Table 86. Middle East and Africa Human Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
Table 87. Middle East and Africa Human Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
Table 88. Middle East and Africa Human Coagulation Factor VII Sales by Type (2020-2025) & (K Units)
Table 89. Middle East and Africa Human Coagulation Factor VII Sales by Application (2020-2025) & (K Units)
Table 90. Human Coagulation Factor VII Key Raw Materials, Industry Status and Trend
Table 91. Human Coagulation Factor VII Key Raw Materials and Upstream Suppliers
Table 92. Human Coagulation Factor VII Clients Status and Trend
Table 93. Human Coagulation Factor VII Typical Clients
Table 94. Human Coagulation Factor VII Distributors
Table 95. Human Coagulation Factor VII Market Trends
Table 96. Human Coagulation Factor VII Market Drivers
Table 97. Human Coagulation Factor VII Market Challenges
Table 98. Human Coagulation Factor VII Market Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Coagulation Factor VII Product Picture
Figure 2. Global Human Coagulation Factor VII Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Human Coagulation Factor VII Sales Market Share by Type in 2024 & 2031
Figure 4. Prefilled Syringe Product Picture
Figure 5. Vial Product Picture
Figure 6. Global Human Coagulation Factor VII Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Human Coagulation Factor VII Sales Market Share by Application in 2024 & 2031
Figure 8. Congenital Hemophilia
Figure 9. Acquired Hemophilia
Figure 10. Other
Figure 11. Human Coagulation Factor VII Report Years Considered
Figure 12. Global Human Coagulation Factor VII Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Coagulation Factor VII Market Size 2020-2031 (US$ Million)
Figure 14. Global Human Coagulation Factor VII Sales 2020-2031 (K Units)
Figure 15. Global Human Coagulation Factor VII Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Human Coagulation Factor VII Revenue Market Share by Region (2020-2031)
Figure 17. Global Human Coagulation Factor VII Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Human Coagulation Factor VII Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Human Coagulation Factor VII Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 20. Global Human Coagulation Factor VII Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Human Coagulation Factor VII Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Human Coagulation Factor VII Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 23. Prefilled Syringe of Human Coagulation Factor VII Revenue Market Share by Application, 2024 VS 2031
Figure 24. Vial of Human Coagulation Factor VII Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Human Coagulation Factor VII Sales Share by Manufacturer in 2024
Figure 26. Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Prefilled Syringe Market Sales Proportion by Manufacturer in 2024
Figure 28. Vial Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Human Coagulation Factor VII Revenue 2020-2031 (US$ Million)
Figure 30. North America Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 31. North America Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Human Coagulation Factor VII Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Human Coagulation Factor VII Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 36. Asia-Pacific Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 37. Europe Human Coagulation Factor VII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Human Coagulation Factor VII Sales Market Share by Country (2020-2031)
Figure 39. Europe Human Coagulation Factor VII Revenue Market Share by Country (2020-2031)
Figure 40. Europe Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 41. Europe Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 42. Latin America Human Coagulation Factor VII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Human Coagulation Factor VII Sales Market Share by Country (2020-2031)
Figure 44. Latin America Human Coagulation Factor VII Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 46. Latin America Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Human Coagulation Factor VII Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Coagulation Factor VII Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Type (2020-2025)
Figure 51. Middle East and Africa Human Coagulation Factor VII Sales Market Share by Application (2020-2025)
Figure 52. Human Coagulation Factor VII Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Human Coagulation Factor VII Raw Materials by Region in 2024
Figure 54. Human Coagulation Factor VII Distribution Channels
Figure 55. Global Human Coagulation Factor VII Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Human Coagulation Factor VII Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232